Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mucopolysaccharidosis I under enzyme replacement therapy with laronidase—A mortality case with autopsy report

1 Dec 2005

Abstract excerpt

There is little information about MPS I-related complications during laronidase therapy. We describe the first autopsy report of a young male MPS I patient who died of infection-induced cardiopulmonary failure following 2 years of weekly treatment with laronidase.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glycogen Storage Diseases and Myoclonus
Share to Lysosomal Storage Disorders Research
Share to Trypanosoma species research and implications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16435211
DOI: 10.1007/s10545-005-0211-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Mucopolysaccharidosis I under enzyme replacement therapy with laronidase—A mortality case with autopsy reportPMID 16435211Read ↗

Management of MPS-I using ERT: The Egyptian experienceSemantic proximity Read ↗

Laronidase for cardiopulmonary disease in Hurler syndrome 12 years after bone marrow transplantation.Semantic proximity Read ↗

Enzyme replacement therapy in two patients with an advanced severe (Hurler) phenotype of mucopolysaccharidosis I.Semantic proximity Read ↗

Enzyme replacement therapy in mucopolysaccharidosis type I.Semantic proximity Read ↗

Mortality and cause of death in mucopolysaccharidosis type II—a historical review based on data from the Hunter Outcome Survey (HOS)Semantic proximity Read ↗

Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) with a predominantly cardiac phenotype.Semantic proximity Read ↗

Sub-pleural bullous changes in two adults with Mucopolysaccharidosis type I (Hurler-Scheie).Semantic proximity Read ↗

Usefulness of postmortem biochemistry in forensic pathology: illustrative case reports.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.